Medtronic MDT Cash Flow Statement
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| $4.84B+4.3% | $4.64B-3.2% | $4.79B+2.2% | $4.69B0.0% | $4.69B+9.3% | ||
| $2.96B-4.0% | $3.08B+2.2% | $3.02B+2.4% | $2.95B+3.0% | $2.86B+7.0% | ||
| $457M+1.3% | $451M-0.9% | $455M+5.3% | $432M+0.7% | $429M-0.2% | ||
| —— | —— | —— | -$237M+25.0% | -$316M+6.8% | ||
| $0— | $0— | $0— | $0— | $0-100% | ||
| $136M+5.4% | $129M-10.4% | $144M+8.3% | $133M+8.1% | $123M-0.8% | ||
| —— | —— | —— | —— | —— | ||
| $46M-84.1% | $289M+113% | $136M-36.7% | $215M+2.9% | $209M-57.1% | ||
| —— | —— | —— | —— | —— | ||
| $200M+23.5% | $162M-9.0% | $178M-30.2% | $255M-41.1% | $433M-0.5% | ||
| $7.33B+0.6% | $7.29B+2.4% | $7.11B-0.5% | $7.15B+1.4% | $7.04B-3.4% | ||
| $1.9B+1.5% | $1.88B-1.7% | $1.91B+3.5% | $1.84B-0.9% | $1.86B+1.8% | ||
| —— | —— | —— | —— | —— | ||
| $8.73B+0.2% | $8.71B+3.5% | $8.41B-0.5% | $8.45B+2.7% | $8.23B-2.3% | ||
| $8.11B-1.4% | $8.22B+1.3% | $8.12B-2.8% | $8.35B-1.7% | $8.5B-0.7% | ||
| —— | $148M-37.3% | $236M-33.9% | $357M+43.4% | $249M+14.7% | ||
| -$2.93B-17.0% | -$2.51B+1.1% | -$2.53B-5.7% | -$2.4B-23.7% | -$1.94B+9.6% | ||
| $3.64B+0.3% | $3.63B+0.4% | $3.61B+0.4% | $3.6B+0.3% | $3.59B-0.4% | ||
| $1.04B+18.4% | $874M-8.0% | $950M+9.7% | $866M-73.2% | $3.24B-29.5% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $2.93B+152% | $1.16B— | $0— | ||
| $516M-2.1% | $527M-0.8% | $531M+3.3% | $514M+1.2% | $508M+6.3% | ||
| —— | —— | —— | -$99M+46.2% | -$184M— | ||
| —— | —— | —— | —— | —— | ||
| -$4.75B+8.7% | -$5.21B-6.9% | -$4.87B+2.8% | -$5.01B-14.9% | -$4.36B+18.9% | ||
| —— | —— | —— | $224M+19.1% | $188M+221% | ||
| —— | —— | —— | -$38M-104% | $934M+344% | ||
| $774M+0.8% | $768M-2.9% | $791M+9.3% | $724M-5.0% | $762M-7.6% | ||
| $1.94B+2.1% | $1.9B+1.3% | $1.88B+2.8% | $1.83B+0.4% | $1.82B+4.9% | ||
| $0— | $0— | $0— | $0— | $0-100% | ||
| $200M+23.5% | $162M-9.0% | $178M-30.2% | $255M-41.1% | $433M-0.5% | ||
| -$314M+45.5% | -$576M-0.2% | -$575M-20.3% | -$478M-54.2% | -$310M+3.7% | ||
| $136M+5.4% | $129M-10.4% | $144M+8.3% | $133M+8.1% | $123M-0.8% | ||
| —— | $148M-37.3% | $236M-33.9% | $357M+43.4% | $249M+14.7% | ||
| $8.11B-1.4% | $8.22B+1.3% | $8.12B-2.8% | $8.35B-1.7% | $8.5B-0.7% | ||
| $538M+33.3% | $403.5M+50.0% | $269M+100% | $134.5M— | $0— | ||
| —— | $527M-0.8% | $531M+3.3% | $514M+1.2% | $508M+6.3% | ||
| —— | —— | —— | -$99M+46.2% | -$184M— | ||
| —— | —— | —— | —— | —— | ||
| $1.94B+2.1% | $1.9B+1.3% | $1.88B+2.8% | $1.83B+0.4% | $1.82B+4.9% | ||
| $5.43B+0.3% | $5.41B+3.9% | $5.21B-1.8% | $5.3B+2.3% | $5.19B-5.2% | ||
| $5.43B+0.3% | $5.41B+3.9% | $5.21B-1.8% | $5.3B+2.3% | $5.19B-5.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Medtronic generate?
- Medtronic (MDT) generated $7.3B in operating cash flow over the trailing twelve months.
- What is Medtronic's free cash flow?
- After $1.9B of capital expenditures, Medtronic's free cash flow was $5.4B over the trailing twelve months, up 4.7% year over year.
- Where does Medtronic's cash flow data come from?
- Every line is extracted from Medtronic's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
